The relationship between depression and metabolic control parameters in type 2 diabetic patients: A cross-sectional and feasibility interventional study.
Adi H KhassawnehAbdallah AlzoubiAws G KhasawnehNour AbdoDania Abu-NaserAbdel-Hameed W Al-MistarehiMalak F AlbattahKhalid Ahmed KheirallahPublished in: International journal of clinical practice (2020)
The relationship between depression and T2DM in the context of metabolic syndrome is plausible. However, our results show that escitalopram treatment may not be associated with significant improvement in metabolic control parameters among these patients. Our study has laid the groundwork for future randomised clinical trials with larger sample size and longer follow-up.
Keyphrases
- clinical trial
- end stage renal disease
- metabolic syndrome
- ejection fraction
- chronic kidney disease
- newly diagnosed
- prognostic factors
- depressive symptoms
- open label
- cardiovascular disease
- patient reported outcomes
- insulin resistance
- bipolar disorder
- combination therapy
- cardiovascular risk factors
- smoking cessation